Patents by Inventor Viviana Parreno

Viviana Parreno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200283507
    Abstract: Isolated VHH monoclonal antibodies are disclosed that specifically bind to a Norovirus polypeptide. In some embodiments, the Norovirus is a Genogroup I Norovirus or a Genogroup II Norovirus. In other embodiments, the Norovirus is Norwalk or MD2004 virus. In some embodiments, the monoclonal antibodies specifically bind VP1. Also disclosed are compositions including the disclosed antibodies, nucleic acids encoding these antibodies, expression vectors including the nucleic acids, and isolated host cells that express the nucleic acids. The antibodies and compositions disclosed herein can be used for detecting the presence of a Norovirus in a biological sample, or detecting a Norovirus infection. Also disclosed are methods of treating and/or preventing a NoV infection.
    Type: Application
    Filed: April 21, 2020
    Publication date: September 10, 2020
    Applicants: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Servic, INSTITUTO NACIONAL DE TECNOLOGIA AGROPECUARIA
    Inventors: Karin Bok, Lorena Laura Garaicoechea, Viviana Parreno, Andrea Pamela Aguilar, Marina Bok, Lisbeth Kim Green, Stanislav Vladimirovich Sosnovtsev
  • Patent number: 10662238
    Abstract: Isolated VHH monoclonal antibodies are disclosed that specifically bind to a Norovirus polypeptide. In some embodiments, the Norovirus is a Genogroup I Norovirus or a Genogroup II Norovirus. In other embodiments, the Norovirus is Norwalk or MD2004 virus. In some embodiments, the monoclonal antibodies specifically bind VP1. Also disclosed are compositions including the disclosed antibodies, nucleic acids encoding these antibodies, expression vectors including the nucleic acids, and isolated host cells that express the nucleic acids. The antibodies and compositions disclosed herein can be used for detecting the presence of a Norovirus in a biological sample, or detecting a Norovirus infection. Also disclosed are methods of treating and/or preventing a NoV infection.
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: May 26, 2020
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, Instituto Nacional De Technologia Agropecuaria
    Inventors: Karin Bok, Lorena Laura Garaicoechea, Viviana Parreno, Andrea Pamela Aguilar, Marina Bok, Lisbeth Kim Green, Stanislav Vladimirovich Sosnovtsev
  • Publication number: 20180251527
    Abstract: Isolated VHH monoclonal antibodies are disclosed that specifically bind to a Norovirus polypeptide. In some embodiments, the Norovirus is a Genogroup I Norovirus or a Genogroup II Norovirus. In other embodiments, the Norovirus is Norwalk or MD2004 virus. In some embodiments, the monoclonal antibodies specifically bind VP1. Also disclosed are compositions including the disclosed antibodies, nucleic acids encoding these antibodies, expression vectors including the nucleic acids, and isolated host cells that express the nucleic acids. The antibodies and compositions disclosed herein can be used for detecting the presence of a Norovirus in a biological sample, or detecting a Norovirus infection. Also disclosed are methods of treating and/or preventing a NoV infection.
    Type: Application
    Filed: May 17, 2018
    Publication date: September 6, 2018
    Applicants: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Serv, INSTITUTO NACIONAL DE TECNOLOGIA AGROPECUARIA
    Inventors: Karin Bok, Lorena Laura Garaicoechea, Viviana Parreno, Andrea Pamela Aguilar, Marina Bok, Lisbeth Kim Green, Stanislav Vladimirovich Sosnovtsev
  • Patent number: 10000556
    Abstract: Isolated VHH monoclonal antibodies are disclosed that specifically bind to a Norovirus polypeptide. In some embodiments, the Norovirus is a Genogroup I Norovirus or a Genogroup II Norovirus. In other embodiments, the Norovirus is Norwalk or MD2004 virus. In some embodiments, the monoclonal antibodies specifically bind VP1. Also disclosed are compositions including the disclosed antibodies, nucleic acids encoding these antibodies, expression vectors including the nucleic acids, and isolated host cells that express the nucleic acids. The antibodies and compositions disclosed herein can be used for detecting the presence of a Norovirus in a biological sample, or detecting a Norovirus infection. Also disclosed are methods of treating and/or preventing a NoV infection.
    Type: Grant
    Filed: May 9, 2014
    Date of Patent: June 19, 2018
    Assignees: THE UNITED STATES OF AMERICA, as represented by the Secretary, Dept. of Health and Human Services, INSTITUTO NACIONAL DE TECHNOLOGIA AGROPECUARIA
    Inventors: Karin Bok, Lorena Laura Garaicoechea, Viviana Parreno, Andrea Pamela Aguilar, Marina Bok, Lisbeth Kim Green, Stanislav Vladimirovich Sosnovtsev
  • Patent number: 9371373
    Abstract: Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunization method, and treatment method for rotavirus infections, wherein said domain may be any of the amino acid sequences shown in SEQ ID NO:1, SEQ ID NO:2 or SEQ ID NO:3, and wherein said domains bind to protein VP6 of Group A rotavirus.
    Type: Grant
    Filed: December 3, 2013
    Date of Patent: June 21, 2016
    Assignee: INSTITUTO NACIONAL DE TECHNOLOGIA AGROPECUARIA (INTA)
    Inventors: Thomas Surrey, Aurelien Olichon, Lorena Laura Garaicoeachea, Gisela Ariana Marcoppido, Gladys Viviana Parreño, Silvia Gómez Sebastián, José Angel Martínez Escribano, Andrés Wigdorovitz
  • Publication number: 20160102136
    Abstract: Isolated VHH monoclonal antibodies are disclosed that specifically bind to a Norovirus polypeptide. In some embodiments, the Norovirus is a Genogroup I Norovirus or a Genogroup II Norovirus. In other embodiments, the Norovirus is Norwalk or MD2004 virus. In some embodiments, the monoclonal antibodies specifically bind VP1. Also disclosed are compositions including the disclosed antibodies, nucleic acids encoding these antibodies, expression vectors including the nucleic acids, and isolated host cells that express the nucleic acids. The antibodies and compositions disclosed herein can be used for detecting the presence of a Norovirus in a biological sample, or detecting a Norovirus infection. Also disclosed are methods of treating and/or preventing a NoV infection.
    Type: Application
    Filed: May 9, 2014
    Publication date: April 14, 2016
    Applicants: THE UNITED STATES OF AMERICA, as represented by the Secretary, Dept. of Health and Human Services, INSTITUTO NACIONAL DE TECNOLOGIA AGROPECUARIA
    Inventors: Karin Bok, Lorena Laura Garaicoechea, Viviana Parreno, Andrea Pamela Aguilar, Marina Bok, Lisbeth Kim Green, Stanislav Vladimirovich Sosnovtsev
  • Publication number: 20140178405
    Abstract: Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, vaccine composition, prevention and treatment methods for rotavirus infections, wherein said domain may be any of the amino acid sequences shown in SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3 or SEQ ID No. 4, and wherein said domains bind to protein VP6 of Group A rotavirus.
    Type: Application
    Filed: December 3, 2013
    Publication date: June 26, 2014
    Applicant: Instituto Nacional De Tecnologia Agropecuaria (Inta)
    Inventors: Thomas SURREY, Aurelien OLICHON, Lorena Laura GARAICOEACHEA, Gisela Ariana MARCOPPIDO, Gladys Viviana PARREÑO, Silvia GÓMEZ SEBASTIÁN, José Angel MARTÍNEZ ESCRIBANO, Andrés WIGDOROVITZ
  • Patent number: 8597651
    Abstract: Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunization method, rotavirus detection method, vaccine composition, prevention and treatment methods for rotavirus infections, wherein said domain may be any of the amino acid sequences shown in SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3 or SEQ ID No. 4, and wherein said domains bind to protein VP6 of Group A rotavirus.
    Type: Grant
    Filed: July 24, 2008
    Date of Patent: December 3, 2013
    Assignee: Instituto Nacional de Tecnologia Agropecuaria (INTA)
    Inventors: Thomas Surrey, Aurelien Olichon, Lorena Laura Garaicoeachea, Gisela Ariana Marcoppido, Gladys Viviana Parreño, Silvia Gómez Sebastián, José Angel Martinez Escribano, Andrés Wigdorovitz
  • Publication number: 20100330068
    Abstract: Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, vaccine composition, prevention and treatment methods for rotavirus infections, wherein said domain may be any of the amino acid sequences shown in SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3 or SEQ ID No. 4, and wherein said domains bind to protein VP6 of Group A rotavirus.
    Type: Application
    Filed: July 24, 2008
    Publication date: December 30, 2010
    Applicants: ALTERNATIVE GENE EXPRESSION, S.L. (ALGENEX), INSTITUTO NACIONAL DE TECNOLOGIA AGROPECURIA (INTA
    Inventors: Thomas Surrey, Aurelien Olichon, Lorena Laura Garaicoeachea, Gisela Ariana Marcoppido, Gladys Viviana Parreño, Silvia Gómez Sebastián, José Angel Martínez Escribano, Andrés Wigdorovitz